We’re pleased to announce a new notice of special interest (NOSI) (NOT-GM-21-050) to address the urgent need for documenting COVID-19-related outcomes of patients, including those suffering from health disparities, which helps foster COVID-19-related clinical research. Competitive revisions to active IDeA-CTR (U54) awards will be considered for the purpose of sustaining and strengthening the IDeA state COVID-19 patient registry, a component of the National COVID Cohort Collaborative.
Applications are due by June 18, 2021. If you have any questions about this NOSI, please contact Hongwei Gao.
UPDATE: The slides [PDF] and video from this webinar are now available.
We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards for sequencing-based surveillance studies of the SARS-CoV-2 virus to track variants circulating in communities the IDeA and NARCH programs serve. The supplements will support SARS-CoV-2 viral genome sequencing and analysis studies. Projects are expected to expand on or collaborate with ongoing SARS-CoV-2 testing studies or programs in order to leverage resources and deliver results quickly to help address the urgent challenge.
Applications are due by March 31, 2021; see NOT-GM-21-031 for additional details.
If you have any questions about this supplement opportunity, please contact me.
UPDATE: The video and slides [PDF] from the IDeA-CTR webinar are now available.
If you’re preparing an Institutional Development Award Networks for Clinical and Translational Research (IDeA-CTR) grant application for the October 7 receipt date, don’t miss our upcoming webinar:
Thursday, August 6, 3:00-4:30 p.m. ET
During the webinar, IDeA program staff will answer your questions about changes in the goals, objectives, and organizational structures of the IDeA-CTR program, as described in the funding opportunity announcement. Principal investigators who plan to submit new or renewal applications are encouraged to attend.
Continue reading “Webinar for IDeA-CTR Program Applicants”
We’re pleased to announce that the Centers of Biomedical
Research Excellence (COBRE) Phase 3 funding opportunity announcement (FOA) (PAR-20-115) has been reissued.
COBRE supports thematic, multidisciplinary research centers
that establish and strengthen institutional biomedical research capacity in IDeA-eligible
states through three
sequential 5-year phases.
Continue reading “Funding Opportunity: Centers of Biomedical Research Excellence (COBRE) Phase 3”